BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7334663)

  • 1. [HDL-cholesterol in cerebrovascular disease (author's transl)].
    Murai A; Miyahara T; Udaka F
    Rinsho Byori; 1981 Nov; 29(11):1095-100. PubMed ID: 7334663
    [No Abstract]   [Full Text] [Related]  

  • 2. [High density lipoproteins in cerebral stroke: in relation to ischemic heart disease (author's transl)].
    Ide H
    Nihon Ronen Igakkai Zasshi; 1981 May; 18(3):153-9. PubMed ID: 7289182
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipoproteins and apoplexia: in relation to diabetes mellitus (author's transl)].
    Itakura H
    Nihon Ronen Igakkai Zasshi; 1981 May; 18(3):160-3. PubMed ID: 7289183
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum lipid and lipoprotein changes in patients of cerebrovascular diseases (author's transl)].
    Li JZ
    Zhonghua Yi Xue Za Zhi; 1982 Mar; 62(3):142-5. PubMed ID: 6809257
    [No Abstract]   [Full Text] [Related]  

  • 5. [HDL-cholesterol levels in patients with ischemic cerebrovascular disorders before and after suffering apoplectic strokes (author's transl)].
    Kajiyama G; Kawamoto T; Kubota S; Miyoshi A; Yamamda K; Nakagawa K
    Nihon Ronen Igakkai Zasshi; 1980 Nov; 17(6):595-600. PubMed ID: 7206298
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the clinical significance of serum HDL-chol and HDL-PL determination in stroke patient (author's transl)].
    Yoshida K; Wago K
    Rinsho Byori; 1980 Jul; 28(7):665-9. PubMed ID: 7463760
    [No Abstract]   [Full Text] [Related]  

  • 7. [An observation of etiologic contribution of lipoproteins to cerebrovascular disorders (author's transl)].
    Takamatsu S; Sato T; Sakuta S; Mizuno S; Takamatsu M; Metoki H
    Nihon Ronen Igakkai Zasshi; 1981 May; 18(3):143-7. PubMed ID: 7289180
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood serum levels of cholesterol, HDL-cholesterol and triglycerides in diseases of the cerebrovascular circulation].
    Szirmai I; Fendler K; Gömöri E
    Orv Hetil; 1988 Jun; 129(25):1307-11. PubMed ID: 3194125
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of lipoprotein abnormalities in stroke patients (author's transl)].
    Murai A; Miyahara T; Tanaka T; Udaka F; Fujimoto N
    Nihon Ronen Igakkai Zasshi; 1981 May; 18(3):164-8. PubMed ID: 7289184
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination methods and clinical significance of HDL-cholesterol (author's transl)].
    Fukui I
    Rinsho Byori; 1981 Nov; 29(11):1071-8. PubMed ID: 7334659
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma HDL-cholesterol concentration in diabetics (author's transl)].
    Ueda Y
    Rinsho Byori; 1981 Nov; 29(11):1085-9. PubMed ID: 7334661
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of weight change on HDL cholesterol (author's transl)].
    Suyama Y; Shibata H; Matsuzaki T; Kumagai S
    Nihon Ronen Igakkai Zasshi; 1982 Jan; 19(1):1-7. PubMed ID: 7069933
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis by a computer on the blood concentrations of HDL-cholesterol and lipid metabolites in obesity (author's transl)].
    Hayashi T; Taba S; Ogata A; Yamamoto K; Imazu T; Kaneda Y
    Rinsho Byori; 1982 Apr; 30(4):461-5. PubMed ID: 7098082
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of relevant factors of HDL cholesterol (author's transl)].
    Shibata H; Suyama Y; Matsuzaki T
    Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):456-62. PubMed ID: 7339084
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ischemic heart disease and HDL-cholesterol (author's transl)].
    Abe K; Kuramochi M
    Rinsho Byori; 1981 Feb; 29(2):131-4. PubMed ID: 7230530
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum lipids in normal subjects, coronary heart disease and cerebrovascular disease.
    Rattanapanone V; Jiviriyawat Y
    J Med Assoc Thai; 1983 Dec; 66(12):779-84. PubMed ID: 6676441
    [No Abstract]   [Full Text] [Related]  

  • 17. [VLDL catabolism: implication for negative-risk of HDL-cholesterol against ischemic heart disease (author's transl)].
    Nambu S; Tsushima M; Nishioeda Y; Murakami K; Ko H; Hayashi R; Nakao Y; Kajikawa T; Kushiro H
    Rinsho Byori; 1981 Nov; 29(11):1101-7. PubMed ID: 7334664
    [No Abstract]   [Full Text] [Related]  

  • 18. [HDL-cholesterol in the appearance of mid-beta lipoprotein band (author's transl)].
    Ikeda H; Maeda J
    Rinsho Byori; 1981 Nov; 29(11):1079-84. PubMed ID: 7334660
    [No Abstract]   [Full Text] [Related]  

  • 19. [HDL-cholesterol in patients with gout (author's transl)].
    Yamanaka H; Watanabe T; Kawai T; Nishioka K; Sakurabayashi I; Mikanagi K
    Ryumachi; 1981 Mar; 21(1):38-41. PubMed ID: 7280873
    [No Abstract]   [Full Text] [Related]  

  • 20. [Initial results of the determination of HDL-cholesterol in patients with cerebrovascular strokes and multiple sclerosis (the significance of the ratio between HDL-cholesterol and total cholesterol)].
    Opavský J; Bartek J
    Acta Univ Palacki Olomuc Fac Med; 1982; 102():299-310. PubMed ID: 6242584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.